New drug cocktail aims to tame tough breast cancer

NCT ID NCT05458674

First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 23 times

Summary

This study tests a combination of three drugs (tucatinib, eribulin, and trastuzumab) in 30 people with advanced HER2+ breast cancer that has not responded to prior treatments. The goal is to see if the combo can shrink tumors or slow cancer growth while monitoring side effects. Participants must have already tried certain other therapies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cancer Care Northwest

    RECRUITING

    Spokane Valley, Washington, 99216, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • George Washington Medical Faculty Associates

    RECRUITING

    Washington D.C., District of Columbia, 20037, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • New Mexico Cancer Care Alliance

    RECRUITING

    Albuquerque, New Mexico, 87131, United States

    Contact Email: •••••@•••••

    Contact

  • Swedish Cancer Institute

    RECRUITING

    Issaquah, Washington, 98029, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Colorado

    RECRUITING

    Aurora, Colorado, 80045, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University of Wisconsin Carbone Cancer Center

    RECRUITING

    Madison, Wisconsin, 53792, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.